Skip to Main Content

News

Results: 37 Articles found.
  • Possible drug induced retinal maculopathy secondary to long-term use of pentosan polysulfate sodium (Elmiron)

    Aug 11, 2020 11:10 AM

    Pentosan polysulfate sodium (PPS) was approved by the Food and Drug Administration (FDA) in 1985 for the relief of bladder pain or discomfort associated with Interstitial Cystitis (IC)/Painful Bladder Syndrome (PBS). Currently, it is the only FDA approved oral agent for the treatment of IC/PBS. Due to the limited availability of alternative treatments for IC/PBS, many patients may rely on long-term continuation of this drug for relief of symptoms.

    Read More
  • Menefee

    AUGS Diversity and Inclusion Task Force Call for Volunteers

    Jun 07, 2020 03:00 PM

    After my President’s Perspective on racial equity and diversity, AUGS received numerous letters expressing thoughts on our sub-specialty history, member concerns, and the health care disparities related both to our patients and research within our field. I was able to listen and talk with many members and this was a powerful experience for me personally and confirmed the need for all of us to make sure that AUGS is a welcoming society for all our members.

    Read More
  • Menefee

    Call for Volunteers and Board Nominations

    Jun 02, 2020 12:50 PM

    We are making our annual Call for Volunteers and Board Nominations to move our Society forward. Now more than ever we need our members to engage and participate in AUGS. It is in large part because of the numerous committed volunteers over the years that AUGS and our specialty are where we are today.​

    Read More
  • Joint Statement on Re-introduction of Hospital and Office-based Procedures in the COVID-19 Climate for the Practicing Urogynecologist and Gynecologist

    Apr 29, 2020 04:49 PM

    Traditionally, surgical procedure prioritization depends on illness acuity and resource availability after shared decision making with patients. During an emergency such as the COVID-19 pandemic, decisions must take into consideration new influences on the safety of benign gynecologic procedures. Prioritization of patients must be fluid as the pandemic waxes and wanes and is likely different in the peaks than the troughs of infection incidence.

    Download Document
  • Menefee

    PFD Week 2020 Vancouver

    Feb 20, 2020 01:16 PM

    As many of you are preparing your abstracts for PFD Week 2020, I wanted to update everyone on a few changes to the annual meeting structure. In an effort to be responsive to attendee and member feedback on the annual meeting, the Board created a task force to take a closer look at how we could retain the meeting’s excellent reputation, while allowing for new ideas and concepts to ensure the meeting continues to be our flagship event each year.

    Read More
  • Menefee

    Announcing the AUGS Innovation Lectureship Award

    Jan 06, 2020 03:53 PM

    Wishing everyone a Happy New Year and looking forward to a great 2020 for our society. It is with excitement that I announce on behalf of the AUGS Board the inaugural AUGS Innovation Lectureship at PFD Week 2020 in Vancouver. Looking toward our future, this award is intended to honor members of the society and national/global community at large who have made major innovative contributions to the field of female pelvic medicine and reconstructive surgery.

    Read More
  • Menefee

    Looking Towards 2020

    It is with great pleasure that I write my first President’s Perspective. First, I want to thank everyone for contributing to the successful AUGS/IUGA Joint Scientific Meeting in Nashville. This meeting was our largest to date, with 2,237 in attendance.

    Read More
  • Cundiff__5b1_5d2018

    State of the Society

    Oct 17, 2019 10:32 AM

    As I complete my Presidency of AUGS, I would like to bring to you a summary of the State of the Society. 2019 has been a busy year with many developments that impact our specialty but are outside of our direct control.

    Read More
Results: 37 Articles found.
 
Close